Portugal - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, Portugal Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry increased 6.6% year on year. At $178,795,494.19 Million PPP in 2019, the country was number 24 comparing other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry. Portugal is overtaken by Turkey, which was ranked number 23 at $231,137,855.44 Million PPP and is followed by Finland with $174,819,523.26 Million PPP. United States topped the ranking with $70,565,318,932.39 Million PPP in 2019, that is +3.3% compared to 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland recorded the best 5 years average growth at +43.9% per year, while Lithuania recorded the worst performance at -42.6% per year.
Loading...
| Date | Million US Dollars PPP |
|---|---|
| 2019 | 178,795,494.19 |
| 2018 | 173,166,878.76 |
| 2017 | 173,853,214.86 |
| 2016 | 154,064,840.28 |
| 2015 | 127,480,008.93 |
How does Portugal rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
| # | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
| 2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
| 23 |
#23
Turkey
|
231,137,855.44 | 2019 | +3.0 % | +3.1 % | View data | |
| 24 |
#24
Portugal
|
178,795,494.19 | 2019 | +3.3 % | +6.6 % | View data | |
| 25 |
#25
Finland
|
174,819,523.26 | 2019 | +2.0 % | +3.3 % | View data | |